Literature DB >> 29623349

Three cases of intracystic papillary neoplasm of gallbladder.

Naruki Mizobuchi1, Jiro Munechika2, Nobuyuki Takeyama3, Yoshimitsu Ohgiya2, Nobuyuki Ohike4, Ryosuke Abe2, Noritsugu Takahama2, Osamu Miyagami2, Kumi Hatano2, Kumiko Ishizuka2, Masanori Hirose2, Takehiko Gokan2.   

Abstract

Intracystic papillary neoplasm (ICPN) of gallbladder is a comparatively new concept and is described as pre-malignant lesions in Nakanuma et al. (In: Bosman et al. (eds) WHO Classification of Tumours of the Digestive System, World Health Organization of Tumours, IARC, Lyon, 2010). ICPN with high-grade intraepithelial neoplasia is understood to include intraepithelial carcinoma or noninvasive carcinoma. And lesions with invasive cancer components are classified as ICPN with an associated invasive carcinoma [1]. According to Adsay et al., more than half of patients diagnosed with ICPN have invasive cancer components (Adsay et al., Am J Surg Pathol 36:1279-1301, 2012).Polypoid masses in the gallbladder including benign, malignant, and non-neoplastic lesions have been called gallbladder polyps, and ICPN is also a polypoid lesion in the gallbladder. However, it is difficult to differentiate between them. In the literature, it is said that the possibility of malignancy is high in lesions exceeding 1 cm (Terzi et al., Surgery 127:622-627, 2000). And there are few reports on characteristic imaging findings of ICPN.We have experienced three cases (two females and one male) of ICPN and report our imaging findings. Contrast-enhanced computed tomography revealed large papillary polypoid lesions approximately 2-4 cm in size in the gallbladder. Findings suggestive of deformation of the gallbladder wall and extrinsic progression were absent in all cases. T2-weighted magnetic resonance imaging revealed intense signals and diffusion-weighted imaging showed high intensity. Expanding of the gallbladder was seen in case 1, and a tumor stalk-like appearance was seen in the papillary mass in cases 2 and 3. Surgery was performed in all three cases and ICPN was diagnosed pathologically. The cancer was localized to the mucosa, with no infiltration of surrounding tissue in all three cases.

Entities:  

Keywords:  CT; Intracystic papillary neoplasm (ICPN); MRI

Mesh:

Substances:

Year:  2018        PMID: 29623349     DOI: 10.1007/s00261-018-1595-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

Review 1.  Diagnosis and Treatment of Gallbladder Polyps: Current Perspectives.

Authors:  Osman Nuri Dilek; Sebnem Karasu; Fatma Hüsniye Dilek
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jan-Jun

2.  Progression to invasive cancer after snare polypectomy of intracholecystic papillary neoplasms during gallbladder stone removal by percutaneous transhepatic choledochoscopy: a case report.

Authors:  Chi Hyuk Oh; Seok Ho Dong
Journal:  BMC Gastroenterol       Date:  2020-11-30       Impact factor: 3.067

3.  Intracholecystic papillary neoplasm arising in a patient with pancreaticobiliary maljunction: a case report.

Authors:  Toshimitsu Iwasaki; Yasuhiro Otsuka; Yoichi Miyata; Takahiro Einama; Hironori Tsujimoto; Hideki Ueno; Sho Ogata; Yoji Kishi
Journal:  World J Surg Oncol       Date:  2020-11-09       Impact factor: 2.754

4.  Intracholecystic papillary neoplasm associated with invasive carcinoma of the remnant gallbladder after subtotal cholecystectomy: a case report.

Authors:  Yusuke Watanabe; Naoki Mochidome; Hiromichi Nakayama; Yoshitaka Gotoh; Taro Setoguchi; Shunya Sunami; Reiko Yoneda; Yurina Ochiai; Kimihisa Mizoguchi; Hirofumi Yamamoto; Takashi Ueki
Journal:  Surg Case Rep       Date:  2022-02-21

5.  Natural history of intracholecystic papillary neoplasm (ICPN): a rare case of ICPN whose natural history was closely followed by ultrasound.

Authors:  Daisuke Koike; Hiroyuki Kato; Yukio Asano; Masahiro Ito; Satoshi Arakawa; Norihiko Kawabe; Masahiro Shimura; Chihiro Hayashi; Takayuki Ochi; Kenshiro Kamio; Toki Kawai; Hironobu Yasuoka; Takahiko Higashiguchi; Akihiko Horiguchi
Journal:  BMC Gastroenterol       Date:  2022-08-08       Impact factor: 2.847

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.